Clinical Trials Browser

Triple Negative Breast Neoplasms × Androgen Antagonists × Clear all

NCT07340541 2026-02-09

EVOLVE-BDT

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms